Document ID: FDA-2016-N-0001-0042
Agency: fda
Document Type: Notice
Title: Endocrinologic and Metabolic Drugs Advisory Committee; Amendment of
Notice
Posted Date: 2016-04-06T04:00Z

[Federal Register Volume 81, Number 66 (Wednesday, April 6, 2016)]
[Notices]
[Page 19978]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07906]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-0001]

Endocrinologic and Metabolic Drugs Advisory Committee; Amendment 
of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
amendment to the notice of a meeting of the Endocrinologic and 
Metabolic Drugs Advisory Committee. This meeting was announced in the 
Federal Register of March 17, 2016. The amendment is being made to 
reflect a change in the Date and Time portion of the document. The Date 
of the meeting is changed to May 24, 2016. There are no other changes.

FOR FURTHER INFORMATION CONTACT: LaToya Bonner, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg.31, Rm. 2417, Silver Spring, MD 20993-0002, 301-
796-9001, FAX: 301-847-8533, EMDAC@fda.hhs.gov, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area). Please call the Information Line for up-to-date 
information on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of March 17, 2016 
(81 FR 14448), FDA announced that a meeting of the Endocrinologic and 
Metabolic Drugs Advisory Committee would be held on May 25, 2016. On 
page 14449, in the first column, the Date and Time portion of the 
document is changed to read as follows:
    Date and Time: The meeting will be held on May 24, 2016, from 8 
a.m. to 5 p.m.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: April 1, 2016.
Jill Hartzler Warner,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2016-07906 Filed 4-5-16; 8:45 am]
 BILLING CODE 4164-01-P